glp 1 and hashimotos GLP-1 Receptor Agonists: A Promising Therapy for Modern Lifestyle Diseases with Unforeseen Challenges glp 1 hashimoto The GLP-1

Phentermine may have a role in specific scenariossuch as short-term use (typically 12 weeks or less) in patients with no cardiac historybut evidence increasingly favors GLP-1 monotherapy as a first-line approach due to better safety margins and sustained weight loss

You may also discuss potential risks or side effects

Patients have often been struggling with obesity for 5, 10, 15 years

doi: 10.1136/bmj.l4898 60 BethelMAPatelRAMerrillPLokhnyginaYBuseJBMentzRJet al

Telogen Effluvium Associated With Weight Loss: A Single-Center Retrospective Study 7

This raises an important question worth sitting with: if a disrupted microbiome can reduce the effectiveness of GLP-1 signaling, then the state of your gut bacteria may influence how well your GLP-1 medication actually works